3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
NET
1
Endocrine
1
Conditions
Breast Neoplasms
13
Prostatic Neoplasms
9
Obesity
7
Ovarian Neoplasms
5
Colorectal Neoplasms
5
Malnutrition
4
Uterine Cervical Neoplasms
3
Urinary Bladder Neoplasms
3
Radiation Injuries
3
Polycystic Ovary Syndrome
3
Pancreatic Neoplasms
3
Overweight
3
Motor Activity
3
Gastrointestinal Neoplasms
3
Weight Loss
2
Triple Negative Breast Neoplasms
2
Stomach Neoplasms
2
Sarcoma
2
Multiple Myeloma
2
Leukemia, Lymphocytic, Chronic, B-Cell
2
Glioblastoma
2
Fatigue
2
Endometrial Neoplasms
2
Cachexia
2
Burkitt Lymphoma
2
Weight Gain
1
Uterine Cervical Dysplasia
1
Unspecified Adult Solid Tumor, Protocol Specific
1
Sezary Syndrome
1
Sexuality
1
Interventions
lutetium Lu 177 dotatate
2
Lutetium-177
2
Liquid Biopsy
2
pentetreotide
1
fluorodopa F 18
1
copper dotatate CU-64
1
Yttrium-90
1
Surveys and Questionnaires
1
Surgical Procedures, Operative
1
Standard of Care
1
Specimen Handling
1
Single Photon Emission Computed Tomography Computed Tomography
1
Resveratrol
1
Respiratory Therapy
1
Referral and Consultation
1
Quality of Life
1
Poly(ADP-ribose) Polymerase Inhibitors
1
Palliative Care
1
Nutrition Assessment
1
Needles
1
Magnetic Resonance Spectroscopy
1
Endoscopic Mucosal Resection
1
Diet Therapy
1
Data Collection
1
Cryosurgery
1
Control Groups
1
Colectomy
1
Betaine
1
90Y-octreotide, DOTA-Tyr(3)-
1
3-Iodobenzylguanidine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Neuroendocrine Tumors
×
Diet Therapy
×
Clear all
NCT02481804
2024-05-06
DIVIT-pilot
University Medical Center Groningen
Phase NA
Completed
15 enrolled